Summary
Transitional cell carcinoma of the bladder has a high recurrence rate after local treatment. Progression to a higher stage occurs in 10–30% of the recurrent tumors, and early detection of potentially progressive tumors is important. In the current study morphometric, densitometric, and chromatin textural features of nuclei of superficial bladder tumors (pTa-T1) were studied to determine the value of karyometric features in the prediction of tumor progression. Seventy-two histological samples from 36 patients, consisting of both the primary and the first recurrent superficial tumor, were analyzed. Patients were divided into two groups: those with tumor progression, defined as an increase in tumor stage or occurrence of metastatic disease, and those without. Discriminant analysis on four karyometric features resulted in correct prediction of prognosis of 78% and 97% in the primary and recurrent tumors, respectively (P<0.001). Tumor grade and stage did not offer additional information concerning prognosis. Karyometric analysis of recurrent superficial transitional cell tumors can be useful in selecting patients who need a more aggressive therapy. However, tumor characteristics of recurrent tumors varied and continuous evaluation of the karyometric features is necessary for early detection of an increase in the malignant potential of the tumor.
Similar content being viewed by others
References
Althausen AF, Prout GP, Dall JJ (1976) Non-papillary carcinoma of the bladder associated with carcinoma in situ. J Urol 116:575
Ausfeld R, Beer M, Muhlethaler JP (1987) Adjuvant intravesical chemotheraphy of superficial bladder cancer with monthly doxorubicin or intensive mitomycin. Eur Urol 13:10
Bengtsson E, Eriksson O, Holmquist J, Torsten J, Nordin B, Stenkvist B (1981) Segmentation of cervical cells: detection of overlapping cell nuclei. Comp Graph Image Proc 16:382
Blomjous ECM, Schipper NW, Baak JPA, Vos W, de Voogt HJ, Meijer CJLM (1989) The value of morphometry and DNA flow cytometry in addition to classic prognosticators in superficial urinary bladder carcinoma. Am J Clin Pathol 91:243
Böcking A, Aufferman W, Vogel H, Schlöndorff G, Goebbels R (1985) Diagnosis and grading of malignancy in squamous epithelial lesions of the larynx with DNA cytophotometry. Cancer 56:1600
Bowie JE, Young IT (1977) An analysis technique for biological shape: II. Acta Cytol 21:455
De Prez C, de Launoit Y, Kiss R, Petein M, Pasteels J-L, Verhest A, van Velthoven R (1990) Computerized morphonuclear cell image analysis of malignant disease in bladder tissues. J Urol 143:694
Gilbert Ha, Logan JL, Kagan AR, Friedman HA, Cove JK, Fox M, Muldoon TM, Lonni YW, Rowe JH, Cooper JF, Nussbaum H, Chan P, Rao A, Starr A (1978) The natural history of papillary transitional cell carcinoma of the bladder and its treatment in an unselected population on the basis of histologic grading. J Urol 119:448
Green LF, Mulcahy JJ, Warren MM (1973) Benign papilloma or papillary carcinoma of the bladder? J Urol 110:205
Helander K, Kirkhus B, Iversen OH, Johansson SL, Nilsson S, Vaage S, Fjordvang H (1985) Studies on urinary bladder carcinoma by morphometry, flow cytometry, and light microscopic malignancy grading with special reference to grade II tumours. Virchows Arch [A] 408:117
Heney NM, Ahmed S, Flanagan MJ, Frable W, Corder MP, Haferman MD, Hawkins IR (1983) Superficial bladder cancer: progression and recurrence. J Urol 130:1083
Huland H, Klöppel G, Otto U, Feddersen I, Brachmann W, Hubmann H, Kaufmann J, Knipper W, Lantzius-Beninga F (1988) Cytostatic intravesical instillation in patients with superficial bladder carcinoma for the prevention of recurrent tumors. Eur Urol 14:202
Jakse G, Loidl W, Seeber G, Hofstädter F (1987) Stage T1, grade 3 transitional cell carcinoma of the bladder: an unfavorable tumor? J Urol 137:39
Kaubisch S, Lum BL, Reese J, Freiha F, Torti FM (1991) Stage T1 bladder cancer: grade is the primary determinant for risk of muscle invasion. J Urol 146:28
Kurth KH, Schröder FH, Tunn U, Ay R, Pavone-Macaluso M, Debruyne F, de Pauw M, Dalesio O, ten Kate F and members of the European Organization for Research on Treatment of Cancer, Genito-Urinary Tract Cancer Cooperative Group (1984) Adjuvant chemotherapy of superficial transitional cell bladder carcinoma: preliminary results of a european organization for research on treatment of cancer randomized trial comparing doxorubicin hydrochloride, ethoglucid and transurethral resection alone. J Urol 132:257
Lutzeyer W, Rübben H, Dahm H (1982) Prognostic features in superficial bladder cancer: an analysis of 315 cases. J Urol 127:250
Montironi R, Scarpelli M, Pisani E, Ansuini G, Marinelli F, Mariuzzi G (1985) Noninvasive papillary transitional-cell tumors. Karyometric and DNA-content analysis. Anal Quant Cytol Histol 7:337
Mufti GR, Virdi JS, Hall MH (1990) Long-term follow-up of intravesical Epodyl therapy for superficial bladder cancer. Brit J Urol 65:32
Ooms ECM, Blok APR, Veldhuizen RW (1985) The reproducibility of a quantitative grading system of bladder tumors. Histopathology 9:501
Ooms ECM, Kurver PHJ, Veldhuizen RW, Alons CL, Boon ME (1983) Morphometric grading of bladder tumors in comparison with histologic grading by pathologists. Hum Pathol 14:144
Prout GR, Koontz WW, Coombs LJ, Hawkins IR, Friedell GH (1983) Long term fate of 90 patients with superficial bladder cancer randomly assigned to reccive or not to receive Thiotepa. J Urol 130:677
Rübben H, Deutz EJ, Hofstädter F, Meyers W (1990) Treatment of low and high risk superficial bladder tumors (SBT). Prog Clin Biol Res 350:61
Shinka T, Hirano A, Uckado Y, Ohkawa T (1990) Clinical study of prognostic factors of superficial bladder cancer treated with intravesical Bacillus Calmette-Guérin. Br J Urol 66:35
Soloway MS (1988) Intravesical therapy for bladder cancer. Urol Clin N Am 15:661
Soloway MS, Jordan AM, Murphy WM (1989) Rationale for intravesical chemotherapy in the treatment and prophylaxis of superficial transitional cell carcinoma. EORTC Genitourinary Group Monogr 6 [BCG in superficial bladder cancer]:215
Tribukait B, Gustafson H, Esposti PL (1982) The significance of ploidy and proliferation in the clinical and biological evaluation of bladder tumours: a study of 100 untreated cases. Br J Urol 54:130
van der Poel HG, Boon ME, Kok LP, Tolboom J, van der Meulen B, Ooms ECM (1988) Can cytomorphometry replace histomorphometry for grading of bladder tumours? Virchows Arch [A] 413:249
van der Poel HG, Boon ME, Kok LP, van der Meulen EA, van Caubergh RD, de Bruijn WC, Debruyne FMJ (1991) Morphometry, densitometry, and chromatin pattern analysis of plastic-embedded histologic material from transitional cell carcinoma of the bladder. Anal Quant Cytol Histol 13:307
van der Poel HG, Boon ME, Kok LP, van der Meulen B, Ooms ECM (1988) Can cytomorphometry replace histomorphometry for the grading of bladder carcinoma? Virchows Arch [A] 413:249
van der Poel HG, Schaafsma HE, Vooijs GP, Debruyne FMJ, Schalken JA (1992) Quantitative light microscopy in urologic oncology. J Urol 148:1
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van der Poel, H.G., van Caubergh, R.D., Boon, M.E. et al. Karyometry in recurrent superficial transitional cell tumors of the bladder. Urol. Res. 20, 375–381 (1992). https://doi.org/10.1007/BF00922753
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00922753